STIM
Neuronetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.71
+19.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 11.55x
- Price / sales
- 1.33x
- Price / cash flow
- -22.58x
Enterprise value
- Enterprise value
- $277.0M
- EV / sales
- 1.79x
- EV / EBITDA
- -14.01x
- EV / EBIT
- -12.12x
- Market cap
- $206.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026